One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Search from 250 M+ research papersSearch from 250 M+ research papers
Open Accesshttps://doi.org/10.1182/blood-2019-122765
Copy DOI Journal: Blood |  Publication Date: Nov 13, 2019 |
 Citations: 15 |
Affiliation: Harvard University, Dana-Farber Cancer Institute, Janssen (United States), Hospital Clínic de Barcelona, Consorci Institut D'Investigacions Biomediques August Pi I Sunyer, Centre Hospitalier Universitaire de Nantes, Institute of Cancer Research, Medical University of Silesia, Falun Hospital, University of Calgary, Instituto de Investigación Biomédica de Salamanca, Kyiv City Clinical Oncology Center, Karolinska University Hospital, Karolinska Institutet, City Clinical Hospital, Botkin Hospital, Levine Cancer Institute, Nagoya City University, General University Hospital in PragueRandomized, Open-Label, Non-Inferiority, Phase 3 Study of Subcutaneous (SC) Versus Intravenous (IV) Daratumumab (DARA) Administration in Patients with Relapsed or Refractory Multiple Myeloma: Columba Update
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
